P.A. Frey

Synthesis and NMD A Antagonistic Properties of the Enantiomers of 4‐(3‐phosphonopropyl)piperazine‐2‐carboxylic acid (CPP) and of the unsaturated analogue (<i>E</i>)‐4‐(3‐phosphonoprop‐2‐enyl)piperazine‐2‐carboxylic acid (CPP‐ene)

Bernard Aebischer, P.A. Frey, H. P. HAERTER et al. · Helvetica Chimica Acta · 1989 · 109 citations

Piperazine‐2‐carboxylic Acid, Organic Chemistry, Pharmacotherapy +20

Anticonvulsant activity of the NMDA antagonists, d(−)4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and d(−)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy

Smita S. Patel, Astrid G. Chapman, Joanne L. Graham et al. · Epilepsy Research · 1990 · 90 citations

Molecular Pharmacology, Neurophysiology, Primate Model +13

Evaluation of a competitive NMDA antagonist (<scp>D</scp>‐CPPene) in feline focal cerebral ischemia

M. Chen, Ross Bullock, David I. Graham et al. · Annals of Neurology · 1991 · 65 citations

Receptor Antagonist, Pharmacotherapy, Social Sciences +20

The Biosynthesis and Processing of Proteins in the Mouse 7S Nerve Growth Factor Complex

Thomas L. J. Darling, Petro E. Petrides, Pierre Béguin et al. · Cold Spring Harbor Symposia on Quantitative Biology · 1983 · 50 citations

Molecular Biology, Peripheral Nerve, Cellular Physiology +18

The pharmacology of SDZ EAA 494, a competitive NMDA antagonist

David Lowe, Murat Emre, P.A. Frey et al. · Neurochemistry International · 1994 · 27 citations

Biochemistry, Medicine, Competitive Nmda Antagonist +8